Sam Bott, PharmD, currently serves as the Associate Director of Rx Business Insights at Galderma, a position held since 2025. Prior to this, they were a Consultant for Emerging Pharma at ZS from 2021 to 2022 and a Senior Life Science Consultant at L.E.K. Consulting from 2022 to 2023. Sam has also accumulated experience as a Medical Outcomes Liaison at Akebia Therapeutics and as an Associate Consultant in Market Access Strategy Consulting at IQVIA. Earlier in their career, they worked as a Research Consultant at Vivaleas and held intern roles at Veterans Affairs Hospital and Pharmalogic. Sam earned their Doctor of Pharmacy degree from the University of Pittsburgh School of Pharmacy in 2019 after completing pharmacy prerequisites at Marshall University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices